Tau and neurodegenerative disorders.


The mechanisms that render tau a toxic agent are still unclear, although increasing evidence supports the assertion that alterations of tau can directly cause neuronal degeneration. In addition, it is unclear whether neurodegeneration in various tauopathies occurs via a common mechanism or that specific differences exist. The aim of this review is to provide an overview of tauopathies from bench to bedside. The review begins with clinicopathological findings of familial and sporadic tauopathies. It includes a discussion of the similarities and differences between these two conditions. The second part concentrates on biochemical alterations of tau such as phosphorylation, truncation and acetylation. Although pathological phosphorylation of tau has been studied for many years, recently researchers have focused on the physiological role of tau during development. Finally, the review contains a summary of the significance of tauopathy model mice for research on neurofibrillary tangles, axonopathies, and synaptic alteration.

DOI: 10.1515/bmc.2010.017

5 Figures and Tables

Cite this paper

@article{Motoi2010TauAN, title={Tau and neurodegenerative disorders.}, author={Yumiko Motoi and Naruhiko Sahara and Taiki Kambe and Nobutaka Hattori}, journal={Biomolecular concepts}, year={2010}, volume={1 2}, pages={131-45} }